Does Novavax’s Covid vaccine cause fewer side effects?

Published by: NBC News
Published on: November 19, 2023
By Amy Maxmen

Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax Covid-19 vaccine in mid-October soon after it was finally recommended in the United States. Like many people with autoimmune diseases, she wants to protect herself from a potentially devastating Covid infection.

Kissane’s autoimmune arthritis seems to make her susceptible to unusual vaccine side effects. After getting an mRNA booster last year, her joints ached so painfully that her doctor prescribed steroids to dampen the inflammation. She still considers the mRNA vaccines “miraculous,” knowing Covid could be far worse than temporary aches.

Comments closed

vaccines

Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far

Published October 16, 2023

Published by: Scientific American
Published on: October 16, 2023
By Sara Reardon

As the updated COVID vaccines roll out around the country, one more competitor has joined the mix. In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it targets a SARS-CoV-2 variant, XBB.1.5, which is a descendant of Omicron.

Comments closed

vaccines

EU delays approval of Novavax’s revised COVID vaccine

Published October 15, 2023

Published by: Reuters
Published on: October 15, 2023

European Union (EU) regulators have delayed a decision to give approval for Novavax’s (NVAX.O) variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.

The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.

Comments closed

vaccines

Novavax touts non-mRNA COVID-19 vaccine, hopeful to meet domestic production deadline

Published October 4, 2023

Published by: Ottawa Citizen / The Canadian Press
Published on: October 4, 2023
By Laura Osman

The last remaining manufacturer to offer an alternative to mRNA COVID-19 vaccines in Canada is hopeful it will meet the government’s 2024 deadline to make the shots domestically.

Comments closed

Novavax

Novavax espère toujours fabriquer un vaccin contre la COVID-19 au Canada

Published October 4, 2023

Published by: Le Devoir / La Presse canadienne
Published on: October 4, 2023
By Laura Osman

The last manufacturer to offer an alternative to COVID-19 mRNA vaccines in Canada hopes to meet the government’s 2024 deadline for domestic dose production.

Novavax, based in Maryland, USA, held a press conference on Wednesday to tout the safety and efficacy of its new vaccine, which targets newer strains of COVID-19.

Comments closed

vaccines

FDA authorizes Novavax’s updated COVID vaccine for fall 2023

Published October 3, 2023

Published by: CBS News
Published on: October 3, 2023
By Alexander Tin

The Food and Drug Administration announced Tuesday it had authorized Novavax’s updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.

Comments closed

vaccines

Updated Covid-19 vaccines are coming mid-September, officials say

Published August 25, 2023

Published by: CNN
Published on: August 25, 2023
By Brenda Goodman

Covid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, CDC and FDA officials said.

Comments closed

Tag: Novavax